Literature DB >> 30938182

The association between side effects and adherence to antidepressants among primary care community-dwelling older adults.

Raymond Milan1, Helen-Maria Vasiliadis1,2.   

Abstract

Aims: To evaluate the association between adherence to antidepressants and self-reported side effects while considering their tolerability among primary care community-dwelling older adults.
Methods: This is a secondary analysis of data available for 137 individuals participating in the third wave of the Étude sur la Santé des Aînés - Services study (2015-2017) conducted among older adults aged 65 years and older. Adherence to antidepressants was assessed with the 4-item Medication Assessment Questionnaire. Side effects were also self-reported from a list of 20 potential side effects related to antidepressant use, while considering their tolerability (tolerable and non-tolerable) and were then grouped into seven categories specific to organ or function systems. Multilevel logistic regression analyses were carried out to assess the association between adherence and the presence of side effects accounting for participants nested within primary health clinics.
Results: In this study, 69.3% of participants were adherent to their antidepressants and 30.7% were non-adherent. Participants reporting sleep disturbance (OR = 0.58, 95% CI = 0.47-0.72), gastrointestinal system (OR = 0.64, 95% CI = 0.45-0.92), and nervous system (OR = 0.60, 95% CI = 0.48-0.78) related side effects were less likely to be adherent to their antidepressants. Participants reporting palpitations were more likely to adhere to antidepressants (OR = 2.20, 95% CI = 1.03-4.67). With regards to severity, participants reporting non-tolerable nervous system related side effects were less likely to be adherent (OR = 0.37, 95% CI = 0.26-0.53) and those reporting non-tolerable gastrointestinal system related side effects reported higher adherence to antidepressants (OR = 1.82, 95% CI = 1.08-3.08).
Conclusion: Adherence to antidepressants was associated with side effects, and more precisely with sleep disturbance, gastrointestinal and nervous systems side effects.

Entities:  

Keywords:  Antidepressants; adherence; drug safety; seniors; side effects

Mesh:

Substances:

Year:  2019        PMID: 30938182     DOI: 10.1080/13607863.2019.1594165

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  6 in total

Review 1.  Lifestyle Choices and Brain Health.

Authors:  Jacobo Mintzer; Keaveny Anne Donovan; Arianne Zokas Kindy; Sarah Lenz Lock; Lindsay R Chura; Nicholas Barracca
Journal:  Front Med (Lausanne)       Date:  2019-10-04

Review 2.  Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review.

Authors:  Danielle Hen-Shoval; Aron Weller; Abraham Weizman; Gal Shoval
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

3.  Association of Antidepressant Prescription Filling With Treatment Indication and Prior Prescription Filling Behaviors and Medication Experiences.

Authors:  Jenna Wong; Siyana Kurteva; Aude Motulsky; Robyn Tamblyn
Journal:  Med Care       Date:  2022-01-01       Impact factor: 2.983

4.  Perceived Need for Mental Health Care and Associated Factors and Outcomes in Older Adults Consulting in Primary Care.

Authors:  Catherine Lamoureux-Lamarche; Djamal Berbiche; Helen-Maria Vasiliadis
Journal:  Can J Psychiatry       Date:  2021-11-26       Impact factor: 5.321

Review 5.  Medication Management Frameworks in the Context of Self-Management: A Scoping Review.

Authors:  Lauren Cadel; Stephanie R Cimino; Teagan Rolf von den Baumen; Kadesha A James; Lisa McCarthy; Sara J T Guilcher
Journal:  Patient Prefer Adherence       Date:  2021-06-16       Impact factor: 2.314

6.  Physical activity, physical self-perception and depression symptoms in patients with major depressive disorder: a mediation analysis.

Authors:  Esra Görgülü; Miriam Bieber; Tobias Engeroff; Kirsten Zabel; Semra Etyemez; David Prvulovic; Andreas Reif; Viola Oertel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-07-19       Impact factor: 5.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.